Skip to content Skip to footer
Subscribe Now
NEWS

Saluda Medical Reports Full Launch of EVA Sensing Technology for Spinal Cord Stimulation in the US

Shots:

  • Saluda Medical has reported full commercial launch of EVA in the US following its approval in Dec 2024
  • Saluda Medical will present new clinical data on EVA and the Evoke SmartLoop System at ASPN 2025, featuring 11 abstracts, one oral presentation, & over 37 total publications, incl. 36-month efficacy results from the EVOKE Study
  • EVA objectively scans & analyzes the spinal cord to deliver personalized therapy with precision & it is compatible with all Evoke SmartLoop Systems, which optimize outcomes by sensing, measuring & adjusting stimulation based on each patient’s ECAP biomarker to maintain therapy

Ref: PRNewswire  | Image: Saluda Medical| Press Release

Related News:- Johnson & Johnson MedTech Reports the US Launch of VOLT Wrist and Proximal Humerus Plating Systems

PharmaShots! Your go-to media platform for customized news ranging for multiple indications. For more information connect with us at connect@pharmashots.com

Tags:

You May Also Like

Merck Kga
December 23, 2025
The NMPA Approves Merck KGaA’s Pimicotinib for Tenosynovial Giant Cell Tumor (TGCT)
Merck
April 23, 2025
Merck’s Keytruda Regimen Receives Health Canada’s Approval for Malignant Pleural Mesothelioma (MPM)
October 13, 2025
BMS to Strengthen its Cell Therapy Portfolio with $1.5B Orbital Therapeutics Acquisition

Contact US

 Second Floor, H-65, Sector 63 Noida, Uttar Pradesh, INDIA – 201301

 +1 (289) 778-4900

 connect@pharmashots.com

OUR INFORMATION

About Us

Announcements

FAQ

Privacy Policy

Terms & Conditions

Grievance Redressal

FOLLOW US

Contact US

Copyright © 2018 – 2026 PharmaShots – All Rights Reserved.

We chose the name PharmaShots to reflect our mission of delivering concise, high-impact, and actionable insights — or “shots” — for decision-makers across the biopharma and healthcare ecosystem. Each story, update, or insight is designed to be sharp, focused, and easy to consume, helping readers quickly grasp what truly matters in a fast-moving industry.

PharmaShots operates at the intersection of media, insights, and brand visibility for the life sciences industry. Our core offerings include:

  • Curated biopharma and healthcare news & analysis

  • Deep-dive insight reports, lists, and industry rankings

  • Sponsored content and brand storytelling

  • Digital marketing and content distribution

  • Event and congress media partnerships

  • Interviews, viewpoints, and expert-led features

  • Newsletter sponsorships and targeted outreach

All services are designed to help companies communicate value, thought leadership, and innovation to the right audience.

PharmaShots content is created and curated by experienced healthcare writers, editors, analysts, and subject-matter contributors with strong backgrounds in biopharma, life sciences, healthcare research, and business insights.

Our editorial process focuses on clarity, accuracy, and relevance, ensuring every piece delivers insight rather than noise.

Our readers come from across the global healthcare and life sciences ecosystem, including:

  • Healthcare decision-makers

  • Biopharma and biotech professionals

  • Medtech and diagnostics leaders

  • Researchers and clinicians

  • Strategy, business development, and competitive intelligence teams

  • Investors and consultants

  • Digital health and AI innovators

  • Marketing, communications, and market access professionals

They rely on PharmaShots to stay informed, make decisions faster, and spot emerging trends early.

PharmaShots is updated daily with fresh content across news, insights, interviews, and special reports. Updates may occur daily or multiple times per week depending on industry activity, major announcements, and ongoing coverage themes.

Readers can stay connected with PharmaShots through multiple channels:

  • Subscribe to our email newsletter for curated weekly updates

  • Follow PharmaShots on LinkedIn and other social platforms

  • Visit the website regularly for new stories and reports

  • Engage with special editions, rankings, and event coverage

These channels ensure you never miss key developments shaping biopharma and healthcare.

You can reach out to PharmaShots through our website’s contact page or via email at connect@pharmashots.com for inquiries, collaborations, or feedback. Visit pharmashots.com for more details

For general inquiries, partnerships, media collaborations, or support, you can reach us at:

Email: connect@pharmashots.com

Address: PharmaShots Media Private Limited

Second Floor, H-65, Sector 63
Noida, Uttar Pradesh, India – 201301

Phone: India: +91 9582 193319 

US/Canada: +1 (289) 778-4900